Quality of Life 6 Months after COVID-19 Hospitalisation: A Single-Centre Polish Registry

Abstract

Background: The COVID-19 pandemic, which affected the entire global population, had an impact on our health and quality of life. Many people had complications, were hospitalised or even died due to SARS-CoV-2 infection. The health systems of many countries had to radically change their way of functioning and scientists around the world worked intensively to develop a vaccine for the SARS-CoV-2 virus. Aim: The aim of this work is to assess the quality of life of patients who were hospitalised for COVID-19, using the SF-36 questionnaire. Methods: Between May and August 2022, we conducted a telephone assessment of quality of life in patients who were hospitalised for COVID-19 at the Temporary Hospital in Pyrzowice (Silesia, Poland), between November 2021 and January 2022. Results: Quality of life was significantly lower in women (p = 0.040), those with DM2 (p = 0.013), CKD (p = 0.041) and the vaccinated (p = 0.015). Conclusions: People with chronic kidney disease, diabetes mellitus and women had a lower quality of life after COVID-19 disease. However, people who were vaccinated for SARS-CoV-2 had a lower quality of life than non-vaccinated people did. This is possibly due to the higher mean age, and probably the higher disease burden, in the vaccinated group.

Clinical characteristics of COVID-19 patients treated in emergency COVID-19 hospitals in Vietnam: Experience from Phutho province, Vietnam

“…Our data has not covered the effect of vaccination on occurrence of long-term sequelae and this warrants further research in Vietnam. A previous study has suggested that vaccinated patients who then had COVID-19 had a worse quality of life six months after admission with the infection than unvaccinated patients, although this could have been explained by the higher mean age and disease burden in the vaccinated group 31 . Additionally, the results of our data on clinical presentation showed that the majority of patients presented COVID-19 features rather than being asymptomatic.…”

“…In this study, the median age of the study population was 30.0 years (interquartile range [IQR]: 14-41.2). Notably, the unvaccinated cohort were mainly under 18 years old, while the vaccinated groups were over 19 years old, which resulted in a significantly higher median age compared to the unvaccinated cohort (36 [IQR: [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46]] and 36.5 [IQR: 30-47.4] vs. 13.0 [IQR: 9-26], p<0.001). The results were similar to other reported studies which showed that most COVID-19 infections occurred in the 19-30-year age groups [7,8].…”

“…The median age of the patients was 30.0 (IQR 14-41.2). The vaccinated cohort was significantly older than the unvaccinated cohort (median [IQR 25-75%]: 36 [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46] and 36.5 [30-47.4] vs 13.0 [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26], p<0.001), with comorbidities significantly more frequent in the vaccinated groups: hypertension, diabetes mellitus, COPD, taking corticosteroids, smoking and alcohol were all significant at p<0.05. Clinical presentations were significantly presented in the unvaccinated group with 548 cases versus 419 (1 st dose) and 330 cases (2 nd dose), respectively.…”

Functional Tic-like Behaviors: From the COVID-19 Pandemic to the Post-Pandemic Era

“…With few exceptions [ 71 ], it has been shown that the COVID-19 pandemic and the pandemic-related changes have had a considerable impact on patients with neurodevelopmental tics [ 72 , 73 , 74 , 75 , 76 ]. As with the general population [ 77 ], complex long-term effects of this global phenomenon have been documented in patients with Tourette syndrome [ 78 ]. Further longitudinal studies are needed to fully understand the long-term trajectories of functional tic-like behaviors in the post-pandemic era.…”